Avian Influenza and HMPV: Facts and Prevention

As avian influenza makes its steady progression toward mutating into a form with the ability to spread from person to person, we still have time. The virus is most likely a product of gain-of-function research, meaning scientists have been attempting to make the strain more lethal and easier to spread. (1)

Reality Check - Facts So Far

• Death of a patient who contracted bird flu in Louisiana. The patient was older (65) and had preexisting medical conditions that put him in a high-risk category. It is unclear if he perished FROM avian influenza or contracted the virus and died from other causes. (1)
• As of now, only 66 people have been diagnosed with avian influenza in the U.S. The CDC reports risk to the population is still low, with no person-to-person transmission. (2)
• Most cases are mild, with conjunctivitis and cold-like symptoms. Many cases likely go unreported due to the mild nature of symptoms.
• Other than vaccines (which carry grave risks such as ALDENZ, linked to a 1 in 200 chance of death in trials), the CDC and mainstream media are not discussing alternative preventive measures. (3)

Effective prevention methods, such as iodine-based gargles and nasal sprays, are often overlooked despite their efficacy in reducing viral loads.

The Chinese Scare: Human Metapneumovirus (HMPV)

Along similar lines, Human Metapneumovirus (HMPV) has been making headlines with symptoms akin to a severe cold. Media reports have labeled it "severe and deadly," particularly as it circulates in China. Given the mishandling of COVID-19, the public is understandably skeptical of such alarmist tactics. (4)

No Treatment, No Vaccine

HMPV currently has no treatment or vaccine. Preventative measures include avoiding sick people, handwashing, and cleaning contaminated surfaces. Like avian flu, iodine-based gargles and nasal sprays remain an under-discussed but effective option.

Early Intervention

As Dr. Peter McCullough mentioned in a recent interview on Real America’s Voice, early intervention is crucial. Iodine-based nasal sprays and gargles can be effective if used when exposure is suspected, before symptoms appear. Studies show that viruses require 3-7 days to replicate to a level capable of causing infection. Nasal and oral disinfection can prevent the virus from establishing a foothold. (5)

ImmuneMist Kit: Nasal and Oral Cleanse

ImmuneMist Kit is an iodine-based preventive strategy designed for use during and after suspected virus exposure. It effectively reduces viral loads in the nasal cavity and soft palate, where viruses typically multiply.

Contagion Emergency Kit

Sage advice from Dr. McCullough, our Chief Science Officer:

“Get a head start on treatment if symptoms develop by using nasal/throat sprays and gargles. Xylitol, povidone iodine, and saline products all work fine, but the key is to use them twice a day religiously. Spry, Scope, or Listerine can be used for twice-daily gargles. When sick, increase usage to every 4-6 hours. Masks are not effective for stopping the spread of viral illnesses.”

Our Contagion Emergency Kit is a must-have. It includes:

• Generic Tamiflu^TM, effective when started at symptom onset to reduce flu symptoms and duration.
• Budesonide and a handheld nebulizer for respiratory relief.
• Azithromycin, Hydroxychloroquine, and Ivermectin.
• A 40-page guidebook with life-saving advice from our medical team.

Remember, early intervention is key. Don’t wait—it may be too late. Have the Contagion Emergency Kit ready before illness strikes.

Citations

1. Hulscher, N., Leake, J., & McCullough, P. (2024). Journal of Veterinary Science & Technology
2. Louisiana Department of Health
3. McCullough, P., Hulscher, N., & Leake, J. (2025). Substack
4. McCullough, P. (n.d.). Substack
5. Gaaloul Ben Hnia N. et al. (2023). Influenza Other Respir Viruses

Written By Brooke Lounsbury